Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.70
Bid: 27.60
Ask: 28.05
Change: -0.40 (-1.42%)
Spread: 0.45 (1.63%)
Open: 27.45
High: 28.05
Low: 26.95
Prev. Close: 28.10
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership Agreement

27 Mar 2012 14:00

RNS Number : 1858A
IQE PLC
27 March 2012
 



IQE plc

 

IQE selected as partner in $2m Australian Solar Institute programme

 

Cardiff, UK, 27 March 2012: IQE plc (AIM: IQE, "IQE" or the "Group"), the leading global supplier of advanced semiconductor wafer products and services to the semiconductor industry, has been selected as a key CPV wafer supplier by Australian CPV company Silex Systems as part of a $2m programme to develop high efficiency multi-junction solar cells on low-cost large-area silicon substrates.

 

Silex Systems (ASX: SLX) received the $2 million grant from the Australian Solar Institute to support the company's development of solar cell technology which could reduce energy production costs by up to 20%.

 

The aim of the programme is to develop, fabricate, and test novel next-generation multiple-junction solar cells used in the evolving utility scale Concentrating Photovoltaic (CPV) solar power station industry.

 

The key differentiator is the development of a new virtual 'Germanium' substrate wafer-based substrate where a thin layer of Ge is deposited on a Silicon wafer. This will reduce the cost and potentially improve the efficiency of the multiple-junction cells in CPV applications. The new substrates and resulting CPV cell structures will be fully characterised and analysed in the lab and then tested in on-sun in field equipment.

 

The grant from the Australian Solar Institute (ASI) which was established by the Australian Government in 2009 is for the development of high efficiency multi-junction solar cells on low cost large area silicon substrates. The program, by Silex's wholly owned subsidiary Solar Systems, has the potential to reduce the cost of energy production from Concentrating Photovoltaic technologies by up to 20%.

 

Solar Systems will supplement the $2 million grant by providing about $3 million in project funding, with $2 million of in-kind support and $1 million in cash contributions over the three year project duration.

 

Project partner and Silex subsidiary Translucent will provide large area silicon substrate technology for the project, allowing for commercialisation of the technology to be fast tracked.

 

Dr. Andrew Johnson, IQE's CPV Technology Director said:

 

"Silex Systems' selection of IQE as a partner for this programme clearly demonstrates that we are recognised as a key global player in CPV wafer products for advanced, high efficiency solar energy generation. This programme builds on our advanced capabilities in germanium on silicon for CPV applications that we launched in 2010 and compliments the range of CPV technologies in which we are active."

 

Other key CPV partners in the programme include Boeing-owned Spectrolab and Emcore Corporation for multi-junction cell production facilities.

 

These partnerships will allow for volume production of the solar cells, which will be incorporated into Solar Systems' dense array system to characterise the performance of the new CPV modules at the Bridgewater Test Facility in central Victoria.

 

 

 

FURTHER INFORMATION

 

IQE: www.iqep.com

Silex Systems: http://www.silex.com.au/

Australian Solar Institute: www.australiansolarinstitute.com.au/

 

 

CONTACTS:

IQE plc (+44 29 2083 9400)

Press: Chris Meadows

Technical: Dr Andrew Johnson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUQCWUPPGPM
Date   Source Headline
24th Apr 20071:58 pmRNSDirector/PDMR Shareholding
19th Apr 200710:21 amRNSHolding(s) in Company
19th Apr 20078:00 amRNSHolding(s) in Company
13th Apr 20073:16 pmRNSDirector's share options
5th Apr 20073:03 pmRNSDirector/PDMR Shareholding
28th Mar 20077:02 amRNSPreliminary Results
28th Mar 20077:02 amRNSRe Contract
20th Mar 200711:49 amRNSHolding(s) in Company
5th Mar 20079:25 amRNSHolding(s) in Company
22nd Feb 20073:05 pmRNSNotice of Results
14th Feb 20072:35 pmRNSHolding(s) in Company
14th Feb 20072:22 pmRNSHolding(s) in Company
12th Feb 20075:38 pmRNSHolding(s) in Company
6th Feb 20075:14 pmRNSHolding(s) in Company
5th Feb 200712:36 pmRNSHolding(s) in Company
26th Jan 200710:50 amRNSHolding(s) in Company
18th Jan 20071:35 pmRNSAdditional Listing
9th Jan 20073:12 pmRNSAdditional Listing
9th Jan 20073:10 pmRNSDirector/PDMR Shareholding
9th Jan 200710:04 amRNSDirectorate Change
8th Jan 20077:00 amRNSAcquisition Completion
28th Dec 20067:00 amRNSTotal Voting Rights
22nd Dec 20069:55 amRNSDirector/PDMR Shareholding
22nd Dec 20067:38 amRNSTrading Statement
22nd Dec 20067:38 amRNSAcquisition
1st Dec 20062:36 pmRNSHolding(s) in Company
24th Nov 20067:01 amRNSMore Industry Recognition
20th Nov 20063:39 pmRNSAdditional Listing
13th Nov 200611:35 amRNSDirector/PDMR Shareholding
10th Nov 20062:58 pmRNSHolding(s) in Company
10th Nov 20062:48 pmRNSHolding(s) in Company
24th Oct 20065:25 pmRNSHolding(s) in Company
18th Oct 20069:11 amRNSSupplier Agreement
18th Oct 20067:01 amRNSSupplier Agreement
30th Aug 20063:27 pmRNSAdditional Listing
30th Aug 20067:02 amRNSInterim Results
25th Aug 20063:06 pmRNSHolding(s) in Company
25th Aug 20063:04 pmRNSHolding(s) in Company
25th Aug 20069:30 amRNSHolding(s) in Company
22nd Aug 200611:20 amRNSHolding(s) in Company
21st Aug 20064:57 pmRNSHolding(s) in Company
21st Aug 20067:00 amRNSAcquisition
18th Aug 20062:54 pmRNSHolding(s) in Company
18th Aug 20062:52 pmRNSHolding(s) in Company
18th Aug 200612:36 pmRNSHolding(s) in Company
15th Aug 20065:27 pmRNSHolding(s) in Company
15th Aug 200611:17 amRNSEGM Statement
10th Aug 200610:09 amRNSIssue of Equity
2nd Aug 200611:21 amRNSHolding(s) in Company
31st Jul 20064:07 pmRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.